-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Read: This study suggests that one million lives could be saved each year if moderate coffee consumption were generally encouraged globally to reduce the risk of premature death from liver disease.
. Liver disease is one of the killers of human health, according to statistics, about 1 million people die of cirrhosis each year, about 740,000 people die of liver cancer caused by cirrhosis, accounting for more than 3.5% of the total annual death toll.
in order to reduce the incidence and treatment burden of the disease, countries have launched vaccinations against hepatitis B and C and a variety of treatment strategies.
A recent study by researchers from the University of Melbourne and St Vincent's Hospital in Australia found that increased per capita coffee intake has a beneficial effect on reducing liver-related mortality globally, reducing the number of deaths from liver cancer by hundreds of thousands if everyone in the world drinks at least two cups of coffee a day.
study was published in the journal Alimentary Pharmacology and Therapeutics.
For the study, researchers counted liver-related diseases and hepatitis B deaths in each country in the Global Burden of Disease (GBD) database in 2016, using public data from the International Coffee Organization to count the annual coffee consumption per capita in each country.
then added the two sets of data to a model to estimate the potential impact of increased per capita coffee intake on global liver-related mortality.
, a global map of per capita daily coffee intake, shows that globally, there were about 1.24 million liver-related deaths among people over 15 years of age in 2016, with a median liver disease mortality rate of 15 deaths per 100,000 people per year.
Combined with coffee consumption, the model shows that if the global average coffee consumption exceeds two cups per day, the total number of liver-related deaths among people over 15 years of age will be reduced to at least about 715,000, avoiding about 42 per cent of deaths and preventing 7.8 liver-related deaths per 100,000 people per year.
The actual number of liver-related deaths per capita coffee consumption in each region in 2016 and the predicted number of liver-related deaths of more than two or four cups per day, and if per capita coffee intake in all countries increases to four or more cups per day, the global total number of deaths will be reduced by at least 400,000 and 67% of liver-related deaths can be avoided, with a preventable rate of 12.1 liver-related deaths per 100,000 people per year.
, in recent years it has been gradually discovered that drinking coffee improves the biochemistry of the liver and slows the development of cirrhosis.
One of the largest high-quality prospective cohort studies to date, published in 2015, found that drinking two to three cups of coffee a day reduced the risk of cirrhosis by 38 percent, the risk of dying from the disease by 46 percent, and when four cups of coffee or more were drunk a day, the risk of cirrhosis was reduced by 41 percent and the risk of death by 71 percent.
, the study suggests that if moderate coffee consumption were generally encouraged globally to reduce the risk of premature death from liver disease, one million lives could be saved each year.
particularly outside Europe, where coffee consumption is low and the incidence of underlying liver disease is relatively high, the benefits of liver-related mortality are greater.
resources: s1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .